Information Provided By:
Fly News Breaks for April 21, 2017
DHR
Apr 21, 2017 | 08:44 EDT
Argus analyst John Eade says that Danaher's stock has fallen 3% since the company reported a Q1 EPs beat that was driven by items like reduced taxes and lower interest expense. The analyst expects the company's EPS to rise by at least 10% in 2017 and 2018. He believes that the company's recent dividend hike is a sign of confidence and recommends buying the stock on weakness.
News For DHR From the Last 2 Days
DHR
Apr 24, 2024 | 06:40 EDT
Baird raised the firm's price target on Danaher to $271 from $259 and keeps an Outperform rating on the shares. The firm said they reported 1Q results above expectations, helped by respiratory testing and bioprocessing upside. The company saw encouraging bioprocessing trends, with orders growing mid-single-digits, and noted normalization of large customer ordering patterns, with management expecting destocking to be largely complete by 2Q24-end.
DHR
Apr 24, 2024 | 05:28 EDT
Barclays raised the firm's price target on Danaher to $270 from $260 and keeps an Equal Weight rating on the shares post the Q1 report. The company's orders came in above expectations, the analyst tells investors in a research note. The firm says bioprocessing names continue to be favored by investors and that it does not see this changing in the near term.
DHR
Apr 23, 2024 | 09:56 EDT
Notable gainers among liquid option names this morning include Globe Life (GL) $71.33 +4.94, Super Micro (SMCI) $764.85 +47.83, Danaher (DHR) $250.88 +14.79, Kimberly Clark (KMB) $136.87 +7.94, and General Motors (GM) $45.38 +2.17.
DHR
Apr 23, 2024 | 09:04 EDT
Check out this morning's top movers from around Wall Street, compiled by The Fly. UP AFTER EARNINGS... To see the rest of the story go to thefly.com. See Story Here